HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The effect of molsidomine on the conjunctival microcirculation in patients with ischemic heart disease].

Abstract
Sublingual administration of molsidomin in average dose of 3 mg with an interval of 15 and 60 minutes was used in the treatment of 24 patients with ischemic heart disease with stable exertion stenocardia of the II-III functional classes. Course treatment in optimal chosen doses resulted in an improvement of the indices of conjunctival microcirculation and rheological properties of erythrocytes.
AuthorsE A Brovko, V I Denisiuk, P F Kolesnik
JournalVrachebnoe delo (Vrach Delo) Issue 11 Pg. 49-51 (Nov 1989) ISSN: 0049-6804 [Print] Ukraine
Vernacular TitleVliianie molsidomina na kon''iunktival'nuiu mikrotsirkuliatsiiu u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.
PMID2609586 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Molsidomine
Topics
  • Adult
  • Aged
  • Angina Pectoris (drug therapy, physiopathology)
  • Conjunctiva (blood supply, drug effects)
  • Coronary Disease (drug therapy, physiopathology)
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Microcirculation (drug effects, physiology)
  • Middle Aged
  • Molsidomine (therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: